β-Adrenergic Agonist Therapy as a Potential Treatment for Acute Lung Injury
- 1 February 2006
- journal article
- editorial
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 173 (3), 254-255
- https://doi.org/10.1164/rccm.rccm2511003
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Mechanisms of pulmonary edema clearanceAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Incidence and Outcomes of Acute Lung InjuryNew England Journal of Medicine, 2005
- Acute Lung Injury and the Acute Respiratory Distress SyndromeAmerican Journal of Respiratory Cell and Molecular Biology, 2005
- Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Activated Protein C Inhibits Local Coagulation after Intrapulmonary Delivery of Endotoxin in HumansAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Clinically relevant concentrations of β2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury*Critical Care Medicine, 2004
- Transgenic Overexpression of Granulocyte Macrophage-Colony Stimulating Factor in the Lung Prevents Hyperoxic Lung InjuryThe American Journal of Pathology, 2003
- Lung Epithelial Fluid Transport and the Resolution of Pulmonary EdemaPhysiological Reviews, 2002
- Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia.Journal of Clinical Investigation, 1996